Cargando…

Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients

OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic...

Descripción completa

Detalles Bibliográficos
Autores principales: Scully, Paul R., Patel, Kush P., Saberwal, Bunny, Klotz, Ernst, Augusto, João B., Thornton, George D., Hughes, Rebecca K., Manisty, Charlotte, Lloyd, Guy, Newton, James D., Sabharwal, Nikant, Kelion, Andrew, Kennon, Simon, Ozkor, Muhiddin, Mullen, Michael, Hartman, Neil, Cavalcante, João L., Menezes, Leon J., Hawkins, Philip N., Treibel, Thomas A., Moon, James C., Pugliese, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536272/
https://www.ncbi.nlm.nih.gov/pubmed/32771574
http://dx.doi.org/10.1016/j.jcmg.2020.05.029
_version_ 1783590530649686016
author Scully, Paul R.
Patel, Kush P.
Saberwal, Bunny
Klotz, Ernst
Augusto, João B.
Thornton, George D.
Hughes, Rebecca K.
Manisty, Charlotte
Lloyd, Guy
Newton, James D.
Sabharwal, Nikant
Kelion, Andrew
Kennon, Simon
Ozkor, Muhiddin
Mullen, Michael
Hartman, Neil
Cavalcante, João L.
Menezes, Leon J.
Hawkins, Philip N.
Treibel, Thomas A.
Moon, James C.
Pugliese, Francesca
author_facet Scully, Paul R.
Patel, Kush P.
Saberwal, Bunny
Klotz, Ernst
Augusto, João B.
Thornton, George D.
Hughes, Rebecca K.
Manisty, Charlotte
Lloyd, Guy
Newton, James D.
Sabharwal, Nikant
Kelion, Andrew
Kennon, Simon
Ozkor, Muhiddin
Mullen, Michael
Hartman, Neil
Cavalcante, João L.
Menezes, Leon J.
Hawkins, Philip N.
Treibel, Thomas A.
Moon, James C.
Pugliese, Francesca
author_sort Scully, Paul R.
collection PubMed
description OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic valve replacement (TAVR). Bone scintigraphy with exclusion of a plasma cell dyscrasia can diagnose transthyretin-related cardiac amyloid noninvasively, for which novel treatments are emerging. Amyloid interstitial expansion increases the myocardial extracellular volume (ECV). METHODS: Patients with severe AS underwent bone scintigraphy (Perugini grade 0, negative; Perugini grades 1 to 3, increasingly positive) and routine TAVR evaluation CT imaging with ECV(CT) using 3- and 5-min post-contrast acquisitions. Twenty non-AS control patients also had ECV(CT) performed using the 5-min post-contrast acquisition. RESULTS: A total of 109 patients (43% male; mean age 86 ± 5 years) with severe AS and 20 control subjects were recruited. Sixteen (15%) had AS-amyloid on bone scintigraphy (grade 1, n = 5; grade 2, n = 11). ECV(CT) was 32 ± 3%, 34 ± 4%, and 43 ± 6% in Perugini grades 0, 1, and 2, respectively (p < 0.001 for trend) with control subjects lower than lone AS (28 ± 2%; p < 0.001). ECV(CT) accuracy for AS-amyloid detection versus lone AS was 0.87 (0.95 for (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid Perugini grade 2 only), outperforming conventional electrocardiogram and echocardiography parameters. One composite parameter, the voltage/mass ratio, had utility (similar AUC of 0.87 for any cardiac amyloid detection), although in one-third of patients, this could not be calculated due to bundle branch block or ventricular paced rhythm. CONCLUSIONS: ECV(CT) during routine CT TAVR evaluation can reliably detect AS-amyloid, and the measured ECV(CT) tracks the degree of infiltration. Another measure of interstitial expansion, the voltage/mass ratio, also performed well.
format Online
Article
Text
id pubmed-7536272
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75362722020-10-07 Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients Scully, Paul R. Patel, Kush P. Saberwal, Bunny Klotz, Ernst Augusto, João B. Thornton, George D. Hughes, Rebecca K. Manisty, Charlotte Lloyd, Guy Newton, James D. Sabharwal, Nikant Kelion, Andrew Kennon, Simon Ozkor, Muhiddin Mullen, Michael Hartman, Neil Cavalcante, João L. Menezes, Leon J. Hawkins, Philip N. Treibel, Thomas A. Moon, James C. Pugliese, Francesca JACC Cardiovasc Imaging Original Research OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic valve replacement (TAVR). Bone scintigraphy with exclusion of a plasma cell dyscrasia can diagnose transthyretin-related cardiac amyloid noninvasively, for which novel treatments are emerging. Amyloid interstitial expansion increases the myocardial extracellular volume (ECV). METHODS: Patients with severe AS underwent bone scintigraphy (Perugini grade 0, negative; Perugini grades 1 to 3, increasingly positive) and routine TAVR evaluation CT imaging with ECV(CT) using 3- and 5-min post-contrast acquisitions. Twenty non-AS control patients also had ECV(CT) performed using the 5-min post-contrast acquisition. RESULTS: A total of 109 patients (43% male; mean age 86 ± 5 years) with severe AS and 20 control subjects were recruited. Sixteen (15%) had AS-amyloid on bone scintigraphy (grade 1, n = 5; grade 2, n = 11). ECV(CT) was 32 ± 3%, 34 ± 4%, and 43 ± 6% in Perugini grades 0, 1, and 2, respectively (p < 0.001 for trend) with control subjects lower than lone AS (28 ± 2%; p < 0.001). ECV(CT) accuracy for AS-amyloid detection versus lone AS was 0.87 (0.95 for (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid Perugini grade 2 only), outperforming conventional electrocardiogram and echocardiography parameters. One composite parameter, the voltage/mass ratio, had utility (similar AUC of 0.87 for any cardiac amyloid detection), although in one-third of patients, this could not be calculated due to bundle branch block or ventricular paced rhythm. CONCLUSIONS: ECV(CT) during routine CT TAVR evaluation can reliably detect AS-amyloid, and the measured ECV(CT) tracks the degree of infiltration. Another measure of interstitial expansion, the voltage/mass ratio, also performed well. Elsevier 2020-10 /pmc/articles/PMC7536272/ /pubmed/32771574 http://dx.doi.org/10.1016/j.jcmg.2020.05.029 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research
Scully, Paul R.
Patel, Kush P.
Saberwal, Bunny
Klotz, Ernst
Augusto, João B.
Thornton, George D.
Hughes, Rebecca K.
Manisty, Charlotte
Lloyd, Guy
Newton, James D.
Sabharwal, Nikant
Kelion, Andrew
Kennon, Simon
Ozkor, Muhiddin
Mullen, Michael
Hartman, Neil
Cavalcante, João L.
Menezes, Leon J.
Hawkins, Philip N.
Treibel, Thomas A.
Moon, James C.
Pugliese, Francesca
Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
title Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
title_full Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
title_fullStr Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
title_full_unstemmed Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
title_short Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
title_sort identifying cardiac amyloid in aortic stenosis: ecv quantification by ct in tavr patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536272/
https://www.ncbi.nlm.nih.gov/pubmed/32771574
http://dx.doi.org/10.1016/j.jcmg.2020.05.029
work_keys_str_mv AT scullypaulr identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT patelkushp identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT saberwalbunny identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT klotzernst identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT augustojoaob identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT thorntongeorged identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT hughesrebeccak identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT manistycharlotte identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT lloydguy identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT newtonjamesd identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT sabharwalnikant identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT kelionandrew identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT kennonsimon identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT ozkormuhiddin identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT mullenmichael identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT hartmanneil identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT cavalcantejoaol identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT menezesleonj identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT hawkinsphilipn identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT treibelthomasa identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT moonjamesc identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients
AT pugliesefrancesca identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients